These results suggest that the endothelin receptor of HASMCs is of the ETA type. We also studied the effect of ET-1 on the cytosolic [Ca 21]i in HASMCs loaded with fura-2/AM. In 1.3 mM Ca 2+, ET-1 produced a dose-depend ent, biphasic increase in signal with a maximal effect at 10 nM. At this concentration, ET-1 produced a transient increase in [Ca 21]i that reached a peak at 1 min, which was followed by a slow but sustained in crease in [Ca 2+]i. This second phase was attenuated in Ca 2+-deficient medium. Furthermore, ET-1 increased inositol 1,4,5-triphosphate in a time and dose-dependent manner. These results suggest that the endothelin receptors of HASMCs are of the ETA type, which couple with Ca 21 channels.
Endothelin (ET), first purified from the culture medi um of porcine endothelial cells, is the most potent and longest acting constrictor of vascular and non-vascular smooth muscle cells (1) . Cloning and sequencing analysis have shown that at least three genes encode the endothelin family (2) . Receptors for endothelin have been studied in a variety of tissues from a number of species. At least two receptor subtypes have been identified: one has higher affinity for ET-1, ET-2-selective ETA and non-isopeptide selective ETB (3 5) . High-affinity receptors for ET-1 have been demonstrated on cardiac membranes (6, 7) and cul tured vascular smooth muscle cells (8, 9) .
It is well known that activation by ET of the voltage-de pendent Ca 21 channel plays an important role in ET-in duced vasoconstriction (1, 10, 11) . ET is a vasoconstric tor, exerting its effect primarily via the cytosolic free Ca 21 messenger system and phosphatidylinositol breakdown. Although information concerning the effect of ET on vas cular smooth muscle cells has been derived primarily from cells originating from laboratory animals, several studies have used human-derived cells, including human umbilical vein smooth muscle (8, 9) , human myometrial (12) and human bronchial smooth muscle cells (13) . Recently, human aortic smooth muscle cells (HASMCs) have become available for use. In the present study, we characterized the ET receptors in these cells by binding studies and measurement of intracellular Ca 21 content.
MATERIALS AND METHODS

Cell culture
HASMCs imported from Clonetics (San Diego, CA, USA) were purchased from Kurabo (Osaka). They were grown to confluence in monolayers on 225-cm2 culture dishes in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum plus 4 pg/ml of gentamicin un der 5 % C02-9507o air atmosphere at 37C. °The medium was changed every 3 days, and the cells were subcultured every 5 7 days after trypsinization. All cells used in these experiments were under 15 25 population doubling level (PDL). HASMCs were identified by their typical "hill and-valley" morphology and immunofluorescene using a monoclonal antibody against human a-smooth muscle actin, which is a specific marker of differentiated smooth muscle cells.
Membrane preparation
HASMCs in 500-cm2 plastic dishes were washed twice with PBS, scraped into a solution containing 250 mM su crose, 10 MM MgCl2 and 50 mM tris/HC1 (pH 7.4), and then homogenized with a polytron at 4C. After centrifu gation at 2,000 x g for 10 min at 41C, the supernatant was centrifuged at 40,000 x g for 20 min at 4C and the result ing pellet was resuspended in 50 mM tris/HC1 (pH 7.4), 10 MM MgC12 and stored at 801C until for use.
Binding assay Under standard conditions, incubations were carried out at 37C for 90 min in a final volume of 0.5 ml contain ing 50 mM HEPES (pH = 7.5), 10 MM MgC12 0.1 % BSA, 0.2 TIU aprotinin and 0.17 mg/ml bacitracin. The assay was started by the addition of [125I]-ET-1 (30 pM) or
[125I]-ET-3 (30 pM), to membrane from HASMCs (50 100 ug protein). Incubation was terminated by rapid filtration through Whatman GF/C filters (Maidstone, Kent, UK) using a Brandel cell harvester (Geithersburg, MD, USA). The filter was then rinsed 3 times with 3 ml of 50 mM Tris-HC1 (pH = 7.4), 10 MM MgC12 and 0.01 % BSA. Radioactivity retained on the filters was counted by a r-counter (ARC-950; Aroka, Tokyo). Nonspecific binding was determined in the presence of 1 pM ET-1. The protein content of each membrane suspension was measured by the method of Bradford (14) .
Measurements of [Ca2+Ji
Cells were incubated for 30 min with 5 1iM fura-2/AM in HBSS containing 0.05 %BSA and 10 mM glucose. They were washed twice with HBSS, and the slides were se cured in a quartz cuvette in a CAF/ 100 fluorescence spec trometer (Japan Spectroscopic Co., Ltd., Tokyo) equip ped with a thermostatically controlled cell holder. Excita tion wavelengths were set at 340 and 380 nm and emission wavelength at 500 nm. Fluorescence was monitored for 1-3 min until the [Ca 21]i signal stabilized, and a basal
[Ca2+]i measurement was obtained. Thereafter, the cells were subjected to sepcific agonists (e.g., ET-1) or ex perimental perturbations, and [Ca 211i signals were record ed for an additional 10 min. On each coverslip, Ca" calibration was performed by exposing the cells to 101cM ionomycin, followed by 3 mM EGTA. From the ratio of fluorescence at 340 and 380 nm, the [Ca 21]i was deter mined as described by Grynkiewicz et al. (15) using the following equation:
The term (3 is the ratio of fluorescence of fura-2 at 380 nm in zero and saturating Ca2+. Kd is the dissociation con stant of fura-2 for Ca 2+, assumed to be 224 nM.
Inositol phosphate assay
HASMCs were grown to confluence on 6-well plates, and then serum-deprived for 18 hr. Inositol 1,4,5-tri phosphate (Ins(1,4,5)P3) was quantitatively measured in ET-1-stimulated HASMCs by Ins(1,4,5)P3 competition assay. Briefly, before stimulation with ET-1, HASMCs were preincubated with DMEM containing 10 mM LiCI for 5 min at 37C. °The reaction was terminated at desig nated times by adding 10% (W/V) HC1O4. The mixture was kept on ice for 20 min, and then neutralized with ice cold 1.53 M KOH/75 mM Hepes for 20 min. The sample was centrifuged at 2,000 x g for 10 min to remove the KC1O4 precipitate. The supernatant samples (100 pl each) were assayed for Ins (1, 4, 5) P3 with an Ins(1,4,5)P3 assay kit (NEN-Du Pont, Boston, MA, USA). The standard curve was linear from 0.12 to 12.0 pmol of Ins(1,4,5)P3.
Analyses of data
Results are expressed as the mean ±S.E.M. or the mean with 95% confidence limits. Analysis of binding data was performed as previously described (16) . Satistical differ ence between the two means was determined by the non paired Student's t-test. P values less than 0.05 are consi dered to be significant. The regression lines were calculat ed by the least squares method. 
, an endothelin ETA-type-receptor antagonist (17) was pre pared by Yamanouchi Pharmaceutical Co., Ltd. All cul ture reagents were from Gibco Laboratories (Paisley, Scotland), and culture flasks and plates were from Costar (Cambridge, MA, USA). All other chemicals were obtained from commercial sources and were of the highest quality available.
RESULTS
To characterize the specific binding site of ET-1 in the HASMC membrane, a radioligand binding assay was per formed using [125I]-ET-1 and [125I]-ET-3 (Fig. la) . Specific binding was > 70% of the total binding at any concentra tion of [1251]-ET-1 tested and was a saturable process.
Scatchard analysis of the data revealed a single class of high-affinity binding sites with a KD of 97 ± 37 pM and a Bmax of 54± 10 fmol/mg protein (Fig. lb) . Specific bind ing of [125I]-ET-3 was not observed in HASMC mem branes. Figure 2 and Table 1 show the competitive inhibi tion curves and Ki values of nonlabelled ET-1, ET-2, ET 3 and the ETA-selective antagonist, FR139317. ET-1, ET 2 and FR139317 showed similar inhibition curves and K1 values (3.8, 5.7 and 3.6 nM, respectively). ET-3, however, showed 100-fold weaker inhibition (375.3 nM). These results suggested that endothelin receptors in HASMCs are of the ETA type. Figure 3 shows that this increase was dose-dependent (10-11-10-7 M). The response was saturated at 1 x 10-8 M ET-1, and ED50 was estimated to be about 3 x 10-9 M. ET-3 was a weak agonist of [Ca 21]i change (Fig. 3) . Figure 4 and Table 2 . When cells were preincubated for 20 min in Ca2+-free medium containing a mixture of 1 x 10-4 M EGTA and 1 x 10-2 M caffeine, there was a decline in [Ca 2+]i after the addition of ET-1. Similar results were obtained in Ca2+-free medium containing 1 x 10-4 M EGTA and 1 x 10-6 M ryanodine. These find ings suggest that ET-1 induces Ca" mobilization from both caffeine-sensitive intracellular Ca2+ stores and ex tracellular pools.
As shown in Fig. 5a , the addition of 1 x 10-8 M ET-1 in duced a rapid increase in Ins(1,4,5)P3. Levels peaked at 15 to 30 sec, and then gradually declined over the next 90 sec. This increase in Ins(1,4,5)P3 production by ET-1 was dose-dependent (Fig. 5b) (1) proposed that ET-1 acts primarily through di hydropyridine-sensitive Ca2+ channels. However, stimula tion of Ca 21 influx insensitive to dihydropyridine Ca 21 channel antagonists is commonly observed with numer ous Ca2+-mobilizing hormones in various types of cells (24) . We investigated the existence of L-type Ca 2+ chan nels by the addition of KCl or Bay K 8644. These com pounds have induced relatively small changes in [Ca 21]i as compared with the changes they induced in other cells (data not shown). Gardner et al. (9) reported that the den sity or activity of voltage-sensitive Ca2+ channels in cul tured human umbilical artery vascular smooth muscle cells is small. They suggest that the small increase in Ca 21 uptake induced by depolarization was taken up by the endoplasmic reticulum or recycled back to the medium. It would be interesting to know more clearly the mechanism by which ET induces activation of Ca 21 channels in HASMCs and other type of cells.
We demonstrated that caffeine and ryanodine abol ished the ET-1-induced early mobilizatin of [Ca 21] in the absence of extracellular Ca 2+. These two compounds were shown to induce the opening of Ca 21 channels in the endoplasmic reticulum (25, 26) ; in the present study, repeated exposure presumably exhausted the Ca 21 pool of the endoplasmic reticulum. In these conditions, ET-1 induced Ca 21 mobilization from intracellular Ca 21 stores was decreased. Several studies have demonstrated that ET-1 activates phospholipase C to produce IP3 in rat vas cular smooth muscle (27 29) and human umbilical artery (9) . Our findings in the present study that ET-1 stimulates phospholipase C in cultured human aortic vascular smooth muscle cells confirm thse observations.
In conclusion, the present results indicate that activa tion by ET-1 of the ETA receptor is coupled to phos phoinositide hydrolysis and involves a combination of Ca 21 mobilization from intracellular caffeine-sensitive Ca2+ stores and Ca2+ influx from the extracellular compo nent. These results suggest that these transmembrane sig naling pathways play an important role in mechanisms of ET-1-induced vasoconstriction in human aortic vascular smooth muscle. The availability of this cell will facilitate the study of its pathology in human disease states. 
